ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Infectious Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,552Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 208

$3.33M Total Retail Price of All Prescriptions

Rank: 6 out of 208

192 Patients Receiving at Least One Drug in Part D
29%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 192 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 1,420 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

69% of this provider’s prescriptions were for brand-name drugs, compared to an average of 43%.

Prescription Price

$601 was the average price of a prescription from this provider, compared to $300 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
NORVIR 596 103 1 1
TRUVADA 424 71 2 2
PREZISTA 312 56 3 7
REYATAZ 244 40 4 6
EPZICOM 225 69 5 10
ACYCLOVIR 225 58 5 17
ATRIPLA 193 68 7 16
VIREAD 184 62 8 26
ISENTRESS 136 11 9 4
SULFAMETHOXAZOLE-TRIMETHOPRIM 127 37 10 21
ATORVASTATIN CALCIUM 125 47 11 14
VIRAMUNE XR 116 40 12 42
ANDROGEL 102 15 S3 13 30
GEMFIBROZIL 96 45 14 74
PRAVASTATIN SODIUM 91 17 15 18
EMTRIVA 90 27 10 16 84
SELZENTRY 90 47 16 63
SUSTIVA 82 35 18 51
INTELENCE 80 24 19 23
ZIAGEN 79 20 20 115
LEXIVA 77 35 21 69
GABAPENTIN 70 32 22 13
LAMIVUDINE 68 20 23 101
KALETRA 55 12 24 31
LOVAZA 55 0 24 61
ZOLPIDEM TARTRATE 54 12 26 20
METFORMIN HCL 51 14 27 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.